These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12490884)

  • 21. Structure-based virtual screening for low molecular weight chemical starting points for dipeptidyl peptidase IV inhibitors.
    Ward RA; Perkins TD; Stafford J
    J Med Chem; 2005 Nov; 48(22):6991-6. PubMed ID: 16250657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reversed binding of beta-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors.
    Nordhoff S; Cerezo-Gálvez S; Feurer A; Hill O; Matassa VG; Metz G; Rummey C; Thiemann M; Edwards PJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1744-8. PubMed ID: 16376544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders.
    Gorrell MD
    Clin Sci (Lond); 2005 Apr; 108(4):277-92. PubMed ID: 15584901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.
    Leiting B; Pryor KD; Wu JK; Marsilio F; Patel RA; Craik CS; Ellman JA; Cummings RT; Thornberry NA
    Biochem J; 2003 Apr; 371(Pt 2):525-32. PubMed ID: 12529175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
    Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
    Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Kim D; Wang L; Beconi M; Eiermann GJ; Fisher MH; He H; Hickey GJ; Kowalchick JE; Leiting B; Lyons K; Marsilio F; McCann ME; Patel RA; Petrov A; Scapin G; Patel SB; Roy RS; Wu JK; Wyvratt MJ; Zhang BB; Zhu L; Thornberry NA; Weber AE
    J Med Chem; 2005 Jan; 48(1):141-51. PubMed ID: 15634008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV.
    Abe M; Akiyama T; Nakamura H; Kojima F; Harada S; Muraoka Y
    J Nat Prod; 2004 Jun; 67(6):999-1004. PubMed ID: 15217282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin.
    Taldone T; Zito SW; Talele TT
    Bioorg Med Chem Lett; 2008 Jan; 18(2):479-84. PubMed ID: 18068977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV.
    Duffy JL; Kirk BA; Wang L; Eiermann GJ; He H; Leiting B; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2007 May; 17(10):2879-85. PubMed ID: 17350841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent and selective proline derived dipeptidyl peptidase IV inhibitors.
    Edmondson SD; Mastracchio A; Beconi M; Colwell LF; Habulihaz B; He H; Kumar S; Leiting B; Lyons KA; Mao A; Marsilio F; Patel RA; Wu JK; Zhu L; Thornberry NA; Weber AE; Parmee ER
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5151-5. PubMed ID: 15380217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.
    Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH
    Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors.
    Kurukulasuriya R; Rohde JJ; Szczepankiewicz BG; Basha F; Lai C; Jae HS; Winn M; Stewart KD; Longenecker KL; Lubben TW; Ballaron SJ; Sham HL; von Geldern TW
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6226-30. PubMed ID: 17010607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.
    Stremenova J; Krepela E; Mares V; Trim J; Dbaly V; Marek J; Vanickova Z; Lisa V; Yea C; Sedo A
    Int J Oncol; 2007 Oct; 31(4):785-92. PubMed ID: 17786309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
    Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
    Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of BeF3- -modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition.
    Wassmann P; Chan C; Paul R; Beck A; Heerklotz H; Jenal U; Schirmer T
    Structure; 2007 Aug; 15(8):915-27. PubMed ID: 17697997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural analysis of a ternary complex of allantoate amidohydrolase from Escherichia coli reveals its mechanics.
    Agarwal R; Burley SK; Swaminathan S
    J Mol Biol; 2007 Apr; 368(2):450-63. PubMed ID: 17362992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes.
    Deacon CF
    Curr Opin Investig Drugs; 2008 Apr; 9(4):402-13. PubMed ID: 18393107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptidyl peptidase IV inhibitors for the treatment of diabetes.
    Weber AE
    J Med Chem; 2004 Aug; 47(17):4135-41. PubMed ID: 15293982
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases.
    Van der Veken P; Senten K; Kertèsz I; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
    J Med Chem; 2005 Mar; 48(6):1768-80. PubMed ID: 15771423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.
    Magnin DR; Robl JA; Sulsky RB; Augeri DJ; Huang Y; Simpkins LM; Taunk PC; Betebenner DA; Robertson JG; Abboa-Offei BE; Wang A; Cap M; Xin L; Tao L; Sitkoff DF; Malley MF; Gougoutas JZ; Khanna A; Huang Q; Han SP; Parker RA; Hamann LG
    J Med Chem; 2004 May; 47(10):2587-98. PubMed ID: 15115400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.